ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 123 filers reported holding ROYALTY PHARMA PLC in Q2 2020. The put-call ratio across all filers is 0.58 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $414,770 | -28.4% | 15,283 | -18.9% | 0.00% | – |
| Q2 2023 | $579,080 | -13.3% | 18,838 | +1.6% | 0.00% | -100.0% |
| Q1 2023 | $668,068 | +123.7% | 18,542 | +145.3% | 0.00% | – |
| Q4 2022 | $298,692 | -25.0% | 7,558 | -23.6% | 0.00% | – |
| Q3 2022 | $398,000 | +3.6% | 9,895 | +8.4% | 0.00% | – |
| Q2 2022 | $384,000 | +42.2% | 9,132 | +31.8% | 0.00% | – |
| Q1 2022 | $270,000 | -12.3% | 6,931 | -10.2% | 0.00% | – |
| Q4 2021 | $308,000 | +8.1% | 7,720 | +35.6% | 0.00% | – |
| Q4 2020 | $285,000 | -65.7% | 5,694 | -71.2% | 0.00% | -100.0% |
| Q3 2020 | $831,000 | +92.8% | 19,750 | +122.3% | 0.00% | 0.0% |
| Q2 2020 | $431,000 | – | 8,883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |